positionForPages[15]={page:15,positions:[{word:"15",left:0.490344,top:0.945381,width:0.016799,height:0.016265},{word:"百靈佳殷格翰",left:0.449093,top:0.035100,width:0.100793,height:0.012378},{word:"!",left:0.339549,top:0.198333,width:0.007349,height:0.010831},{word:"!",left:0.329451,top:0.384050,width:0.007349,height:0.010831},{word:"!",left:0.839214,top:0.399798,width:0.007350,height:0.010831},{word:"在波士頓的創新合作",left:0.070918,top:0.245047,width:0.211667,height:0.017329},{word:"百靈佳殷格翰在美國波士頓的",left:0.111964,top:0.275678,width:0.229306,height:0.012997},{word:"辦事處是以拓展旗下科學家和組織",left:0.070919,top:0.295798,width:0.270262,height:0.012997},{word:"的網路為目標。百靈佳殷格翰目前",left:0.070919,top:0.316216,width:0.270315,height:0.012997},{word:"與哈佛大學幹細胞研究所的纖維化",left:0.070919,top:0.336635,width:0.270262,height:0.012997},{word:"網路合作，研究治療纖維化疾病的",left:0.070919,top:0.357053,width:0.270315,height:0.012997},{word:"新療法。",left:0.070919,top:0.377471,width:0.070555,height:0.012997},{word:"纖維化的特徵是器官纖維",left:0.131402,top:0.397890,width:0.209903,height:0.012997},{word:"結締組織的病理增生。百靈佳殷格",left:0.070919,top:0.418308,width:0.270315,height:0.012997},{word:"翰與哈佛大學科學家針對特發性肺",left:0.070919,top:0.438727,width:0.270262,height:0.012997},{word:"纖維化、慢性腎臟衰竭和非酒精性",left:0.070919,top:0.459145,width:0.270315,height:0.012997},{word:"脂肪性肝炎之類的疾病展開研究。",left:0.070919,top:0.479563,width:0.270315,height:0.012997},{word:"他們尋找纖維化根本的病理生理機",left:0.070919,top:0.499982,width:0.270262,height:0.012997},{word:"轉，或可成為治療纖維化疾病的轉",left:0.070919,top:0.520400,width:0.270315,height:0.012997},{word:"折點。這個合作的好處是研究員現",left:0.070919,top:0.540819,width:0.270315,height:0.012997},{word:"在得以比以前更深入的開展研究工",left:0.070919,top:0.561237,width:0.270262,height:0.012997},{word:"作，利用協同效應，有效分享資源。",left:0.070919,top:0.581655,width:0.274760,height:0.012998},{word:"跨越國界",left:0.364569,top:0.097561,width:0.094074,height:0.017330},{word:"2015 年百靈佳殷格翰結合公司",left:0.401527,top:0.128193,width:0.232884,height:0.012997},{word:"本身優勢，發揮協同作用的效果，",left:0.364573,top:0.148923,width:0.269875,height:0.012997},{word:"及大膽投入外部創新，為其全球研",left:0.364573,top:0.169342,width:0.269857,height:0.012997},{word:"究組織推出一個新策略。「無國界",left:0.364573,top:0.189760,width:0.269875,height:0.012997},{word:"研究」行動代表的是一個新方法，",left:0.364573,top:0.210178,width:0.269857,height:0.012998},{word:"在百靈佳殷格翰內外的核心治療領",left:0.364573,top:0.230597,width:0.269769,height:0.012997},{word:"域探討科學新方法和創新的技術，",left:0.364573,top:0.251015,width:0.269857,height:0.012997},{word:"或可成為公司未來的重點領域。",left:0.364573,top:0.271434,width:0.246944,height:0.012997},{word:"    生命科學研究的重要性在亞洲",left:0.364573,top:0.291852,width:0.269841,height:0.012997},{word:"快速提升，為某些重點領域的藥",left:0.364573,top:0.312270,width:0.269804,height:0.012998},{word:"學研發帶來重大的新契機。再生醫",left:0.364573,top:0.332689,width:0.269857,height:0.012997},{word:"學正是這些具有優勢的領域之一。",left:0.364573,top:0.353107,width:0.269857,height:0.012997},{word:"與日本京都大學簽訂的三年合作目",left:0.364573,top:0.373526,width:0.269769,height:0.012997},{word:"前已在著手進行。百靈佳殷格翰與",left:0.364573,top:0.393944,width:0.269857,height:0.012997},{word:"京都大學的科學家合作研究新的療",left:0.364573,top:0.414363,width:0.269769,height:0.012997},{word:"法，以恢復聽力受損者的聽力。有",left:0.364573,top:0.434781,width:0.269875,height:0.012997},{word:"這種嚴重問題的人數超過三億六千",left:0.364573,top:0.455199,width:0.269769,height:0.012997},{word:"萬人，其中三千兩百萬人是兒童。",left:0.364573,top:0.475618,width:0.269877,height:0.012997},{word:"由於全球人口老化，而聽力缺損又",left:0.364573,top:0.496036,width:0.269857,height:0.012997},{word:"會隨著年齡俱增，所以預期這種情",left:0.364573,top:0.516455,width:0.269857,height:0.012997},{word:"況的患病率會大幅增加。目前並沒",left:0.364573,top:0.536873,width:0.269857,height:0.012997},{word:"有可恢復聽力缺損的有效療法，患",left:0.364573,top:0.557291,width:0.269857,height:0.012997},{word:"者必須依賴助聽器。",left:0.364573,top:0.577710,width:0.158750,height:0.012997},{word:"    聯合研究小組在構思一個新的",left:0.364573,top:0.598128,width:0.269841,height:0.012997},{word:"概念，希望瞭解內耳受損的毛細",left:0.364573,top:0.618547,width:0.269804,height:0.012997},{word:"胞再生的機轉。對聽力受損的人來",left:0.364573,top:0.638965,width:0.269857,height:0.012997},{word:"說，這些感官細胞已無法正常發揮",left:0.364573,top:0.659383,width:0.269857,height:0.012997},{word:"功能，而新療法的目的就是在於恢",left:0.364573,top:0.679802,width:0.269857,height:0.012997},{word:"復它們的正常功能，克服助聽器的",left:0.364573,top:0.700220,width:0.269857,height:0.012997},{word:"限制。",left:0.364573,top:0.720639,width:0.052917,height:0.012997},{word:"        百靈佳殷格翰於 2016 年 9 月",left:0.364573,top:0.741057,width:0.269815,height:0.012997},{word:"在京都大學醫學創新中心設立辦事",left:0.364573,top:0.761475,width:0.269769,height:0.012998},{word:"處，以建立與日本科學家的其他合",left:0.364573,top:0.781894,width:0.269857,height:0.012997},{word:"作。",left:0.364573,top:0.802312,width:0.035278,height:0.012997},{word:"    為拓展百靈佳殷格翰在聽力缺",left:0.364573,top:0.822731,width:0.269841,height:0.012997},{word:"損領域的研究，「無國界研究」小",left:0.364573,top:0.843149,width:0.269875,height:0.012997},{word:"組最近展開與南京的中國東南大學",left:0.364573,top:0.863567,width:0.269769,height:0.012998},{word:"另一項合作，將著重於以相輔相成",left:0.364573,top:0.883986,width:0.269857,height:0.012997},{word:"的方法恢復聽力。",left:0.364573,top:0.904404,width:0.141111,height:0.012997},{word:"合作抗癌",left:0.658730,top:0.385354,width:0.094074,height:0.017329},{word:" 百靈佳殷格翰癌症研究的目標",left:0.689481,top:0.415985,width:0.239090,height:0.012997},{word:"是研發新療法改善患者的生活。為",left:0.658736,top:0.436105,width:0.269857,height:0.012997},{word:"達到此一目標，本公司持續拓展與",left:0.658736,top:0.456523,width:0.269857,height:0.012997},{word:"學術機構、生物科技公司的合作網",left:0.658736,top:0.476942,width:0.269857,height:0.012997},{word:"路。這些合作著重於新興科技，希",left:0.658736,top:0.497360,width:0.269875,height:0.012997},{word:"望在治療方面能獲得真正的突破，",left:0.658736,top:0.517778,width:0.269857,height:0.012997},{word:"而患者與照顧者還有醫療系統的需",left:0.658736,top:0.538197,width:0.269769,height:0.012997},{word:"求則為研究人員指引方向。",left:0.658736,top:0.558615,width:0.211667,height:0.012997},{word:"      其中一項就是與位於奧地",left:0.658736,top:0.579034,width:0.269776,height:0.012997},{word:"利 因 斯 布 魯 克 的 生 物科 技 公 司",left:0.658736,top:0.599452,width:0.269849,height:0.012997},{word:"ViaTherapeutics 研究癌症療法的",left:0.658736,top:0.619870,width:0.269842,height:0.012998},{word:"策略性合作。二○一五年四月，",left:0.658736,top:0.640289,width:0.269840,height:0.012997},{word:"百 靈 佳 殷 格 翰 的 創 業基 金 成 為",left:0.658736,top:0.660707,width:0.269849,height:0.012997},{word:"ViaTherapeutics 的主要投資人，",left:0.658736,top:0.681126,width:0.269842,height:0.012997},{word:"因為溶解病毒成為癌症研究最具希",left:0.658736,top:0.701544,width:0.269769,height:0.012997},{word:"望的新興療法之一。自 2016 年 9",left:0.658736,top:0.721962,width:0.269873,height:0.012998},{word:"月以來這兩家公司便攜手對破壞癌",left:0.658736,top:0.742381,width:0.269769,height:0.012997},{word:"細胞的溶解病毒展開初期研究。",left:0.658736,top:0.762799,width:0.246945,height:0.012997},{word:"溶解病毒是以感染與破壞",left:0.719220,top:0.783218,width:0.209373,height:0.012997},{word:"癌細胞的方式發揮作用。這個過程",left:0.658736,top:0.803636,width:0.269857,height:0.012997},{word:"也會導致腫瘤抗原的釋放，腫瘤抗",left:0.658736,top:0.824054,width:0.269857,height:0.012998},{word:"原一般是隱藏在身體細胞內，沒有",left:0.658736,top:0.844473,width:0.269857,height:0.012997},{word:"被免疫系統發現，而所謂的原位接",left:0.658736,top:0.864891,width:0.269857,height:0.012997},{word:"種疫苗效應就會引起適應性免疫系",left:0.658736,top:0.885310,width:0.269769,height:0.012997},{word:"統對抗腫瘤細胞的持續性反應。",left:0.658736,top:0.905728,width:0.246945,height:0.012997},{word:"內耳的毛細胞",left:0.071429,top:0.647382,width:0.110872,height:0.013616},{word:"溶解病毒是癌症研究最有希望的",left:0.667740,top:0.112301,width:0.260866,height:0.013616},{word:"新興療法之一。",left:0.667740,top:0.133338,width:0.129352,height:0.013616}]};